Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.8250 (-0.36%) ($0.8250 - $0.8250) on Tue. Feb. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.31% (three month average) | RSI | 33 | Latest Price | $0.8250(-0.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -1.2% a day on average for past five trading days. | Weekly Trend | ANPC declines -10.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) INDA(44%) IVE(44%) JETS(44%) XLB(44%) XHB(43%) | Factors Impacting ANPC price | ANPC will decline at least -3.655% in a week (0% probabilities). VIXM(-36%) UUP(-30%) GLD(-23%) USO(-22%) UNG(-22%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.655% (StdDev 7.31%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $0.97 | 5 Day Moving Average | $0.84(-1.79%) | 10 Day Moving Average | $0.81(1.85%) | 20 Day Moving Average | $0.97(-14.95%) | To recent high | -67.1% | To recent low | 14.6% | Market Cap | $7m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |